vimarsana.com

Page 2 - இந்தியன் நிறுவனம் ஆஃப் அறிவியல் கல்வி மற்றும் ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Tirupati pays tributes to cancer expert

Tirupati pays tributes to cancer expert Updated: Updated: Share Article AAA A file photo of cancer expert Dr. V. Shanta being felicitated by IISER Tirupati Director K.N. Ganesh during her visit to the campus in Tirupati in 2019.   The academic hub of Tirupati paid tributes to veteran cancer expert V. Shanta, who died in Chennai on Tuesday. Dr. Shanta’s last visit to Tirupati was in 2019, when she came to deliver a special address at the Indian Institute of Science Education and Research (IISER Tirupati) campus on the occasion of International Women’s Day. “Extremely hard working and dedicated lady”, IISER Director K.N. Ganesh said while paying tributes to her. Recalling her scintillating and thought-provoking lecture delivered to their students two years back, Dr. Ganesh observed that her talk was the first in the series of lectures planned with famous women scientists on that day every year, as part of the institute’s goal of inspiring Gen-X girls to take up a

Coronavirus | Providing a vaccine to a healthy person without knowing the statistical probability of protection is unethical, says immunologist Vineeta Bal

Coronavirus | Use of a vaccine without knowing its protection potential is unethical, says immunologist Vineeta Bal Updated: Updated: January 08, 2021 23:55 IST Dr. Bal, a former scientist of the National Institute of Immunology, says emergency use approval for COVID-19 vaccines over fears of mutant strains is not reasonable on a scientific basis. Share Article Dr. Vineeta Bal. File   Dr. Bal, a former scientist of the National Institute of Immunology, says emergency use approval for COVID-19 vaccines over fears of mutant strains is not reasonable on a scientific basis. Dr. Vineeta Bal , immunologist and Faculty, Indian Institute of Science Education and Research (IISER), Pune, and former scientist, National Institute of Immunology, New Delhi, disagrees with the emergency use approval given to Covaxin, the COVID-19 vaccine by Bharat Biotech, on the grounds that there was no evidence yet on if and how it provided protection. Excerpts from an interview with The Hindu’s

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.